Cite
HARVARD Citation
Campopiano, M. et al. (2020). No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH. European journal of endocrinology. 183 (4), pp. 411-417. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Campopiano, M. et al. (2020). No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH. European journal of endocrinology. 183 (4), pp. 411-417. [Online].